Sentences with phrase «biomedical company»

You must have good communications skills to get a job as a sales rep for a biomedical company so you can present often complex information in a clear and persuasive way to potential customers.
My objective is to obtain an individual contributor software engineering position with a scientific or biomedical company.
In December Jojo received stem cell therapy through VetStem, a Poway - based biomedical company.
Researchers from LLNL and three other institutions have assisted a Bay Area biomedical company in advancing its Ebola virus detection test for use.
The project will involve intensive interdisciplinary work, combining observational, theoretical, computational and statistical techniques in both academic and industrial environments through the close collaboration with the global biomedical company Randox Laboratories Ltd..
The lipid nanoparticles were developed by biomedical company Arcturus Therapeutics.
The project will involve intensive interdisciplinary work, combining observational, theoretical, computational and statistical techniques in both academic and industrial environments through the close collaboration with the global biomedical company Randox Laboratories Ltd.... continue to the full article
* Alex Thian is a co-founder and chairman of Research Biolabs, which is a fully integrated life science biomedical company, focusing on products distribution, genomic services, and molecular diagnostics.
I do miss it, but it's not a good time for me to be in Albany,» said the father of three, who now works as the CEO of a biomedical company and still practices law.
He currently serves on the Advisory Board of Automation Service (process control device remanufacturer) and as Executive Chairman of Pulse Therapeutics (biomedical company).
Since positioning itself as an OI partner, Bioastra has forged partnerships with some of the world's top pharmaceutical and biomedical companies.
It's a decision which stands to impede access to genes for diagnostic and other purposes, while protecting the right of biomedical companies to extract higher returns for life - saving technology.
The first task was to become world leaders in science, to which end he announced an extra # 50 million funding in stem cell research, and a new partnership of pharmaceutical and biomedical companies that would bring in # 500 million in research and development funds.
Enabled by REDC funding, the Central New York Biotech Accelerator at Loguen's Crossing has gone from a pipe dream to a reality — and it is now helping biotech and biomedical companies from the region and around the globe bring emerging technologies into the marketplace.
There is already concrete interest from international biomedical companies in the shared development of marketable products, Greco reports.
Consulting Agreements: The Good, the Bad, and the Ugly Edward Klees and H. Robert Horvitz, 12 October A leading attorney and a serial entrepreneur explain how to avoid potholes when reviewing consulting agreements with biomedical companies.
That biomedical companies find Singapore an attractive place to set up shop is nothing new.
Grants like this one also help create or maintain good - paying jobs, and promising ideas generated in the lab and proven in clinical settings lead to the creation of new biomedical companies and industries that benefit the overall economy.»
The lawsuit comes after Ohio Attorney General Mike DeWine said Friday an investigation by his office revealed that Planned Parenthood — or the biomedical companies working with the health organization — dispose of aborted fetal parts in landfills.

Not exact matches

One of my favorite examples of this is Vital Vio, a company founded by biomedical engineer Colleen Costell after her grandmother fell sick while in the hospital — the one place Colleen's family thought she'd recover.
After more than a decade of research on the use of machine learning to detect disease - causing mutations in DNA, Brendan Frey, biomedical engineering professor at the University of Toronto, this week launched his company, Deep Genomics, to bring the technology his team developed to the public at large.
For now, the company mostly makes money, it seems, by printing biomaterials for implanting biomedical devices — an area, Tao says, «that has a very huge market and very great potential, especially in China.»
The $ 4.7 - million company won its first contract outside the DOD on good references and luck: the National Institutes of Health wanted a minority - owned company to survey the career opportunities for minorities in biomedical research.
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)-- Exelixis, Inc. (NASDAQ: EXEL) today announced that renowned biomedical research executive Maria C. Freire, Ph.D. has been elected to the company's Board of Directors.
«Her breadth of experience in biomedical research and development can benefit Exelixis greatly as the company recommits its resources to drug discovery and bolstering its pipeline following the successful ongoing commercialization of its lead medicine, CABOMETYX.»
The company will also need a lot more funding, due to the high costs of developing biomedical therapies.
And, get this: the company behind the breakthrough was not a major pharmaceutical company or biomedical manufacturing firm.
• SetPoint Medical, a Santa Clarita, Calif. - based clinical - stage biomedical technology company, raised $ 30 million in Series D funding.
In an editorial in The Journal of the American Medical Association, a Stanford School of Medicine professor criticizes the company for operating in «stealth mode for more than a decade» in order to «change the entire health system» without publishing anything in peer - reviewed biomedical journals.
Prior to joining Sherpa Capital in January 2017, Stacey was Associate Director of Investor and Public Relations for Cerus Corporation (NASDAQ: CERS), a biomedical products company focused in the field of blood transfusion safety.
Follows Kevin Simpson, a second - year Harvard Business School 1990 student, through his job search to his final decision between two very attractive but different job offers: a job as an international marketing manager at Eli Lilly and Co., a leading multinational health product corporation; and a position as the assistant to the president of Haemonetics, an entrepreneurial company in the biomedical equipment field.
StemExpress describes itself as «a multi-million dollar company that supplies human blood, tissue products, primary cells and other clinical specimens to biomedical researchers,» according to the company website.
He started his career as a biomedical technician after serving in the Air Force, and then spent 19 years with Aramark Healthcare Technologies rising to become the company's president, where he built high - performance teams that boosted Aramark's brand in the healthcare services industry.
Johnhan works as a senior engineer at a biomedical device company, and Jeanne's a student services manager at a university.
Some midsized nonprofit organizations that hire biomedical researchers include SRI International (a nonprofit scientific research institute focused on innovative technologies) and the Institute for OneWorld Health, the world's first nonprofit pharmaceutical company, both based in California.
No one — and certainly not NIH — is arguing that financial ties between academic investigators and companies, which are pervasive in biomedical research, should be severed.
Through the program he met Deepak Gopalakrishna, then a genetics graduate student and now his partner at NovoLipid, and Greg Mossinghoff, an experienced biomedical entrepreneur who is now the company's CEO.
In the Ottawa area, approximately 3200 people work in medical and biomedical research and in agri - food technology development, and about 100 biotechnology and medical device companies are located in the city.
Both books also tackle the resulting shift in ethical, aspirational, and legal landscapes in biomedical research as molecular scientists rushed to form industrial ties, universities accelerated patenting and licensing activities, and entrepreneurs created biotechnology companies.
Professional editors for the Science Journals may not have any financial or management interest in any biotechnology, pharmaceutical or biomedical or engineering device, institution or company.
The biomedical device company CryoLife, Inc. is now using the researchers» design to build ring implants for further studies in lab animals, Karp says.
The course «gave me a big vision to understand all the steps going from the research to the application of this research to help people,» says Frias, who hopes to start a company or sell her hip technology to a biomedical device company.
LabMate, a Boston - area, investor - funded, startup company that launched in May, aims to «disrupt» the current science career logjam by bringing the «gig economy» to bioscience through its proprietary online platform, according to co-founder and CEO Craig Russo, who went into business development after completing a bachelor's degree in biological and biomedical sciences and working as a research assistant.
The team's findings have caught the attention of international collagen - based biomedical product manufacturing companies, who are interested in using non-mammalian sources to overcome biological and cultural drawbacks associated with bovine and porcine collagen.
Affymetrix, a biomedical research company?
A common covenant (promise) in biomedical consulting agreements is a statement from the consultant that none of the IP he or she generates for the company in the course of his or her consulting services will infringe on third - party patents.
He has held various technical roles at Andor, now an Oxford Instruments company, advising customers in areas of astronomy and low - light biomedical imaging as well as physical imaging, including X-ray and quantum imaging, and advanced image - data visualization and analysis.
The patent is licensed by the research foundation to the company PepGel LLC, started by the inventors to explore commercialization opportunities in biomedical research and medical device areas.
A psychiatrist whose failure to disclose drug company income contributed to a furor over conflicts of interest in biomedical research has just received his first National Institutes of Health (NIH) grant in 3 years.
«Biopharmaceutical companies support responsible data sharing that protects patient privacy, maintains the integrity of the regulatory review process, and preserves incentives for biomedical research,» said PhRMA Senior Vice President Matt Bennett in a statement.
a b c d e f g h i j k l m n o p q r s t u v w x y z